top
Search terms
Results 1 - 10 of 22 - ordered by :
Pages: 1 2 3
Ejhf

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial ...

European Journal of Heart Failure, Zannad, Faiez, Greenberg, Barry, Cleland, John G.F., Gheorghiade, Mihai, van Veldhuisen, Dirk J., Mehra, Mandeep R., Anker, Stefan D., Byra, William M., Fu, Min, ...

Date : 01/07/2015 Item size : 164716 bytes
Ejhf

Heart failure (HF) remains an important public health problem, which is increasing in incidence and prevalence. [...]the recent PARADIGM-HF study[2] identified the first new class of drugs for the ...

European Journal of Heart Failure, Gold, Michael R., van Veldhuisen, Dirk J., Mann, Douglas L.

Date : 01/02/2015 Item size : 81797 bytes
Ejhf

Email: kfa@med.unc.edu Search for more papers by this author Jalal K. Ghali, Division of Cardiology, Mercer University School of Medicine, Macon, GA, USASearch for more papers by this author J. ...

European Journal of Heart Failure, Adams, Kirkwood F., Ghali, Jalal K., Herbert Patterson, J., Stough, Wendy Gattis, Butler, Javed, Bauman, Jerry L., Ventura, Hector O., Sabbah, Hani, Mackowiak, John ...

Date : 01/05/2014 Item size : 252227 bytes
Ejhf

Email: kfa@med.unc.edu Search for more papers by this author Jalal K. Ghali, Division of Cardiology, Mercer University School of Medicine, Macon, GA, USASearch for more papers by this author J. ...

European Journal of Heart Failure, Adams, Kirkwood F., Ghali, Jalal K., Herbert Patterson, J., Stough, Wendy Gattis, Butler, Javed, Bauman, Jerry L., Ventura, Hector O., Sabbah, Hani, Mackowiak, John ...

Date : 01/05/2014 Item size : 252273 bytes
Ejhf

Prognostic value of N‐terminal pro C‐type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction [2] Other studies demonstrated expression of CNP in the ...

European Journal of Heart Failure, Lok, Dirk J., Klip, IJsbrand T., Voors, Adriaan A., Lok, Sjoukje I., Bruggink‐André de la Porte, Pieta W., Hillege, Hans L., Jaarsma, Tiny, van Veldhuisen, Dirk ...

Date : 01/09/2014 Item size : 213134 bytes
Ehjournal

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF ...

European Heart Journal, Collier, Timothy J., Pocock, Stuart J., McMurray, John J.V., Zannad, Faiez, Krum, Henry, van Veldhuisen, Dirk J., Swedberg, Karl, Shi, Harry, Vincent, John, Pitt, Bertram

Date : 21/09/2013 Item size : 204282 bytes
Ehjournal

Guidelines, Heart failure, Natriuretic peptides, Ejection fraction, Diagnosis, Pharmacotherapy, Neuro-hormonal antagonists, Cardiac resynchronization therapy, Mechanical circulatory support, ...

European Heart Journal, Ponikowski, Piotr, Voors, Adriaan A., Anker, Stefan D., Bueno, Héctor, Cleland, John G. F., Coats, Andrew J. S., Falk, Volkmar, González-Juanatey, José Ramón, ...

Date : 14/07/2016 Item size : 3184731 bytes
Ehjournal

Methods and results In 8592 subjects of the Prevention of Renal and Vascular End-stage Disease (PREVEND), a community-based, middle-aged cohort study, we performed cause-specific hazard analyses to ...

European Heart Journal, Brouwers, Frank P., de Boer, Rudolf A., van der Harst, Pim, Voors, Adriaan A., Gansevoort, Ron T., Bakker, Stephan J., Hillege, Hans L., van Veldhuisen, Dirk J., van Gilst, ...

Date : 14/05/2013 Item size : 289303 bytes
Ehjournal

Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial Methods and ...

European Heart Journal, Hoendermis, Elke S., Liu, Licette C.Y., Hummel, Yoran M., van der Meer, Peter, de Boer, Rudolf A., Berger, Rolf M.F., van Veldhuisen, Dirk J., Voors, Adriaan A.

Date : 07/10/2015 Item size : 265764 bytes
Ehjournal

In this landmark trial patients with systolic heart failure in New York Heart Association (NYHA) class III were included. [...]patients with potassium levels >5 mmol/L were excluded from ...

European Heart Journal, van der Meer, Peter, van Veldhuisen, Dirk J.

Date : 01/04/2011